UltraGene Ebola: Multiplex qPCR for Outbreak Preparedness
https://www.einpresswire.com/article/915738686/ultragene-ebola-multiplex-qpcr-for-outbreak-preparedness
UltraGene Ebola: Multiplex qPCR for Outbreak Preparedness Read More »
ABL Diagnostics Advances NGS for CMV Resistance Monitoring at SEIMC 2026
https://www.einpresswire.com/article/914346495/abl-diagnostics-advances-ngs-for-cmv-resistance-monitoring-at-seimc-2026
ABL Diagnostics Advances NGS for CMV Resistance Monitoring at SEIMC 2026 Read More »
ABL Diagnostics et le CHRU Nancy : premier bilan positif pour le projet PREDAVIR après 6 mois
https://www.einpresswire.com/article/914324401/abl-diagnostics-et-le-chru-nancy-premier-bilan-positif-pour-le-projet-predavir-apr-s-6-mois
ABL Diagnostics Drives EMEA Expansion with VELA Diagnostics Partnership
https://www.einpresswire.com/article/913871100/abl-diagnostics-drives-emea-expansion-with-vela-diagnostics-partnership
ABL Diagnostics Drives EMEA Expansion with VELA Diagnostics Partnership Read More »
ABL Diagnostics Unveils Next-Generation HIV Genotyping Innovation with the Industry’s Broadest Portfolio
https://www.einpresswire.com/article/913010661/abl-diagnostics-unveils-next-generation-hiv-genotyping-innovation-with-the-industry-s-broadest-portfolio
ICAR 2026 – Persistent APOBEC activity in children with longstanding HIV infection: characterization and correlation with clinical outcome
https://www.abldiagnostics.com/wp-content/uploads/2026/05/P190.pdf
ABL Diagnostics Webinar Series
Official Presentation of the DeepChek® HPV Messenger RNA Genotyping Assay Webinar from June 26, 11h00 CET / Paris time https://ablsa-my.sharepoint.com/:f:/p/matthieu_barralon/EoLXon5w0g9AhQlr5kZTO_gBQ9TVE9AcQJuJu_Cw_9Y1Jw?e=OU2KLh
ABL Diagnostics Webinar Series Read More »
ABL Diagnostics Signs Exclusive Distribution Agreement with Riken Genesis to Expand Microbiology Genotyping in Japan
ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Riken Genesis Co., Ltd. (https://www.rikengenesis.jp/en.html). Under this partnership, Riken Genesis will promote and commercialize ABLD’s DeepChek® and UltraGene molecular assays across laboratories in Japan, further strengthening its diagnostics portfolio. Through this collaboration, Riken Genesis
ABL Diagnostics Webinar Series
REAL LIFE EXPERIENCE: The relevance of ultradeep sequencing for low HIV‐1 viral loads and proviruses in the clinical setting Webinar from Tuesday November 19, 2024 – 4pm CEST https://ablsa-my.sharepoint.com/:f:/p/matthieu_barralon/EoLXon5w0g9AhQlr5kZTO_gBQ9TVE9AcQJuJu_Cw_9Y1Jw?e=OU2KLh
ABL Diagnostics Webinar Series Read More »
AdvancedDx Biological Laboratories USA Inc. and Complete Genomics LLC to co-market NGS microbiology solution in the U.S.
NEWBURYPORT, MA, UNITED STATES, September 23, 2024 /EINPresswire.com/ — AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories, is pleased to announce today the execution of a co-marketing agreement to co-promote in the USA Next Generation